Granahan Investment Management, LLC

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1026710 WALTHAM, MA

Position in LGND

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$4,824,542

-$100,731 QoQ

Shares Held

24,165

-7.2% QoQ

Ownership

0.121%

of shares outstanding

% of Portfolio

0.23%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 88.66956341816677.ToString("F0")% Shared 0.ToString("F0")% None 11.33043658183323.ToString("F0")%

Healthcare · as of Mar 31, 2026

Granahan Investment Management, LLC holds $140,186,106 across 24 Biotechnology names. LGND ranks #14 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	STOK	Stoke Therapeutics, Inc.	335,586	$10,926,680
2	VKTX	Viking Therapeutics, Inc.	332,192	$10,809,527
3	CELC	Celcuity Inc.	88,833	$10,139,398
4	SRRK	Scholar Rock Holding Corp	156,314	$7,684,396
5	BBIO	BridgeBio Pharma, Inc.	102,911	$7,642,170
6	SNDX	Syndax Pharmaceuticals Inc	306,321	$7,155,658
7	RYTM	Rhythm Pharmaceuticals, Inc.	77,709	$6,758,351
8	IMNM	Immunome Inc.	307,021	$6,714,549

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$4,824,542	24,165	-7.2%	Shares	Sole	2026-05-15
2025-12-31	$4,925,273	26,050	+4.4%	Shares	Sole	2026-02-17
2025-09-30	$4,421,768	24,962	+175.4%	Shares	Sole	2025-11-14
2022-03-31	$635,993	9,063	-86.9%	Shares	Sole	2022-05-16
2021-12-31	$6,662,205	69,141	-40.9%	Shares	Sole	2022-02-14
2021-09-30	$10,171,572	117,033	-28.0%	Shares	Sole	2021-11-15
2021-06-30	$13,304,368	162,565	-35.1%	Shares	Sole	2021-08-16
2021-03-31	$23,817,189	250,436	+29.5%	Shares	Sole	2021-05-17
2020-12-31	$11,994,732	193,339	+120.1%	Shares	Sole	2021-02-12
2020-09-30	$5,222,262	87,823	+87.3%	Shares	Sole	2020-11-12
2020-06-30	$3,270,931	46,878	-7.2%	Shares	Sole	2020-08-14
2020-03-31	$2,291,562	50,514	—	Shares	Sole	2020-05-12
No filing history on record for this holder in this stock.